AXSOME THERAPEUTICS, INC. Stock-Based Compensation
AXSOME THERAPEUTICS, INC. (AXSM) reported Stock-Based Compensation of $27.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $27.15M, a 10.31% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $23.44M, a 0.56% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $22.73M, a 3.38% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $23.10M, a 6.66% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $93.75M, a 10.01% increase from fiscal 2024.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $85.22M, a 36.09% increase from fiscal 2023.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $62.62M, a 65.99% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $37.73M, a 81.35% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.15M 10-Q · filed 2026-08-10 | $50.59M 10-Q · filed 2026-08-10 | $73.32M derived: sum of 3 quarters · filed 2026-08-10 | $96.42M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $23.44M 10-Q · filed 2026-05-04 | $46.17M derived: sum of 2 quarters · filed 2026-05-04 | $69.27M derived: sum of 3 quarters · filed 2026-05-04 | $93.88M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $22.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $45.83M derived: sum of 2 quarters · filed 2026-02-23 | $70.44M derived: sum of 3 quarters · filed 2026-08-10 | $93.75M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $23.10M 10-Q · filed 2025-11-03 | $47.71M derived: sum of 2 quarters · filed 2026-08-10 | $71.02M 10-Q · filed 2025-11-03 | $93.01M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $24.61M 10-Q · filed 2026-08-10 | $47.92M 10-Q · filed 2026-08-10 | $69.91M derived: sum of 3 quarters · filed 2026-08-10 | $91.56M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $23.31M 10-Q · filed 2026-05-04 | $45.29M derived: sum of 2 quarters · filed 2026-05-04 | $66.95M derived: sum of 3 quarters · filed 2026-05-04 | $88.34M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $21.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $43.65M derived: sum of 2 quarters · filed 2026-02-23 | $65.03M derived: sum of 3 quarters · filed 2026-02-23 | $85.22M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $21.66M 10-Q · filed 2025-11-03 | $43.04M derived: sum of 2 quarters · filed 2025-11-03 | $63.23M 10-Q · filed 2025-11-03 | $82.15M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $21.38M 10-Q · filed 2025-08-04 | $41.57M 10-Q · filed 2025-08-04 | $60.49M derived: sum of 3 quarters · filed 2026-02-23 | $75.33M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $20.19M 10-Q · filed 2025-05-05 | $39.10M derived: sum of 2 quarters · filed 2026-02-23 | $53.95M derived: sum of 3 quarters · filed 2026-02-23 | $69.87M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $18.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $33.76M derived: sum of 2 quarters · filed 2026-02-23 | $49.68M derived: sum of 3 quarters · filed 2026-02-23 | $62.62M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $14.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $30.76M derived: sum of 2 quarters · filed 2024-11-12 | $43.70M 10-Q · filed 2024-11-12 | $54.47M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $28.86M 10-Q · filed 2024-08-05 | $39.63M derived: sum of 3 quarters · filed 2025-02-18 | $48.83M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $12.94M 10-Q · filed 2024-05-06 | $23.71M derived: sum of 2 quarters · filed 2025-02-18 | $32.91M derived: sum of 3 quarters · filed 2025-02-18 | $43.07M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $19.97M derived: sum of 2 quarters · filed 2025-02-18 | $30.13M derived: sum of 3 quarters · filed 2025-02-18 | $37.73M 10-K · filed 2025-02-18 | $37.73M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $19.36M derived: sum of 2 quarters · filed 2023-11-06 | $26.96M 10-Q · filed 2023-11-06 | $26.96M 10-Q · filed 2022-11-07 | $32.85M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | $10.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $17.76M 10-Q · filed 2023-08-07 | $17.76M 10-Q · filed 2022-08-09 | $23.65M derived: sum of 3 quarters · filed 2024-02-23 | $29.38M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | $7.60M 10-Q · filed 2023-05-09 | $7.60M 10-Q · filed 2022-05-02 | $13.49M derived: sum of 2 quarters · filed 2024-02-23 | $19.21M derived: sum of 3 quarters · filed 2024-02-23 | $24.67M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $11.62M derived: sum of 2 quarters · filed 2024-02-23 | $17.07M derived: sum of 3 quarters · filed 2024-02-23 | $20.80M 10-K · filed 2024-02-23 | $20.80M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $11.18M derived: sum of 2 quarters · filed 2022-11-07 | $14.91M 10-Q · filed 2022-11-07 | $20.52M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $5.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $9.19M 10-Q · filed 2022-08-09 | $14.79M derived: sum of 3 quarters · filed 2023-02-28 | $17.66M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $3.73M 10-Q · filed 2022-05-02 | $9.34M derived: sum of 2 quarters · filed 2023-02-28 | $12.21M derived: sum of 3 quarters · filed 2023-02-28 | $16.35M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $8.47M derived: sum of 2 quarters · filed 2023-02-28 | $12.62M derived: sum of 3 quarters · filed 2023-02-28 | $14.76M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $7.02M derived: sum of 2 quarters · filed 2021-11-08 | $9.15M 10-Q · filed 2021-11-08 | $11.96M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $6.28M 10-Q · filed 2021-08-09 | $9.10M derived: sum of 3 quarters · filed 2022-03-01 | $10.25M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $2.13M 10-Q · filed 2021-05-10 | $4.95M derived: sum of 2 quarters · filed 2022-03-01 | $6.10M derived: sum of 3 quarters · filed 2022-03-01 | $6.99M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.97M derived: sum of 2 quarters · filed 2022-03-01 | $4.86M derived: sum of 3 quarters · filed 2022-03-01 | $6.12M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.04M derived: sum of 2 quarters · filed 2020-11-05 | $3.30M 10-Q · filed 2020-11-05 | $3.65M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $888.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.14M 10-Q · filed 2020-08-10 | $2.50M derived: sum of 3 quarters · filed 2021-03-01 | $2.89M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $1.26M 10-Q · filed 2020-05-11 | $1.61M derived: sum of 2 quarters · filed 2021-03-01 | $2.00M derived: sum of 3 quarters · filed 2021-03-01 | $2.48M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $353.08K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $745.75K derived: sum of 2 quarters · filed 2021-03-01 | $1.22M derived: sum of 3 quarters · filed 2021-03-01 | $1.75M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $392.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $867.32K derived: sum of 2 quarters · filed 2019-11-07 | $1.40M 10-Q · filed 2019-11-07 | $1.94M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $474.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.01M 10-Q · filed 2019-08-08 | $1.55M derived: sum of 3 quarters · filed 2020-03-12 | $1.93M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $534.57K 10-Q · filed 2019-05-09 | $1.07M derived: sum of 2 quarters · filed 2020-03-12 | $1.46M derived: sum of 3 quarters · filed 2020-03-12 | $1.94M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $536.92K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $924.96K derived: sum of 2 quarters · filed 2020-03-12 | $1.41M derived: sum of 3 quarters · filed 2020-03-12 | $2.07M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $388.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $871.68K derived: sum of 2 quarters · filed 2018-11-09 | $1.54M 10-Q · filed 2018-11-09 | $1.97M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $483.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.15M 10-Q · filed 2018-08-08 | $1.58M derived: sum of 3 quarters · filed 2019-03-15 | $2.04M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | $663.62K 10-Q · filed 2018-05-08 | $1.10M derived: sum of 2 quarters · filed 2019-03-15 | $1.56M derived: sum of 3 quarters · filed 2019-03-15 | $2.04M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | $434.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $893.19K derived: sum of 2 quarters · filed 2019-03-15 | $1.38M derived: sum of 3 quarters · filed 2019-03-15 | $2.03M 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | $458.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $940.50K derived: sum of 2 quarters · filed 2017-11-08 | $1.60M 10-Q · filed 2017-11-08 | $1.78M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $482.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.14M 10-Q · filed 2017-08-09 | $1.32M derived: sum of 3 quarters · filed 2018-03-07 | $1.68M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $656.19K 10-Q · filed 2017-05-09 | $838.55K derived: sum of 2 quarters · filed 2018-03-07 | $1.20M derived: sum of 3 quarters · filed 2018-03-07 | $1.38M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | $182.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $543.11K derived: sum of 2 quarters · filed 2018-03-07 | $728.52K derived: sum of 3 quarters · filed 2018-03-07 | $803.28K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | $360.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $546.16K derived: sum of 2 quarters · filed 2016-11-14 | $620.92K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $185.41K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | $260.17K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $74.76K 10-Q/A · filed 2016-08-09 | |||||||
| 2014-12-31 | $376.81K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |